MLYS Dividend History - Mineralys Therapeutics Common

Currently (March 2025) Mineralys Therapeutics, Inc. Common Stock does not pay a dividend.

As of March 2025, Mineralys Therapeutics Common (MLYS) does not pay a dividend.

Top Dividend Payers in Biotechnology

Top Dividend Yield in Peer Group
Symbol Market Cap in USD Yield Yield on Cost
MLYS 456m 0.0% -
BION 2,400m 10.2% 10.6%
ORKA 888m 9.99% 10.2%
ABBV 372,048m 4.10% 13.2%
Top Dividend Grower in Peer Group
Symbol Market Cap in USD Grow Rating
MLYS 456m - 0.0%
SECARE 601m 10.4% 59.3%
BIM 14,539m 34.9% 56.7%
AMGN 170,735m 7.06% 69.0%

MLYS Dividend History

No dividends paid yet.

MLYS Dividend History - FAQ

Does MLYS pay dividends?

No, as of March 2025 MLYS does not pay a dividend.

What is the Dividend Yield of MLYS?

As of March 2025, MLYS`s dividend yield is 0.00%. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 14.25.

How often does MLYS pay dividends?

Over the last 12 months (TTM), MLYS has issued 0 dividend payments.

What is the next Ex-Dividend Date for MLYS?

The next ex-dividend date for Mineralys Therapeutics Common (MLYS) is unknown.

What is the Dividend Growth Rate of MLYS?

MLYS's average dividend growth rate over the past 5 years is -% per year.

What is the Yield on Cost of MLYS?

MLYS's 5-Year Yield on Cost is -%. This represents the effective dividend yield for an investor who bought Mineralys Therapeutics Common five years ago. It is calculated as the trailing 12-month dividend cash amount (-) divided by the purchase price five years ago (16.00):

What is the Payout Consistency of MLYS?

MLYS Payout Consistency is 0.0%.

Does MLYS have a good Dividend Yield?

MLYS`s 0.00% Dividend Yield is considered as unknown.

What is the Dividend Payout Ratio of MLYS?

The Dividend Payout Ratio of MLYS is unknown.

What is the Dividend Rating of MLYS?

MLYS`s Overall Dividend Rating is (unknown). Ratings surpassing 60 are regarded as favorable, exceeding 75 are strong, and surpassing 85 are exceptional.

Bonus Section: MLYS Outstanding Shares

What is the Trend of MLYS`s Outstanding Shares?

The Outstanding Shares of Mineralys Therapeutics Common are growing at a rate of 58.46% per year on average over the last 5 years. The Correlation Coefficent of the Outstanding Shares is 90.0%. Investors should be aware that the price of a stock often is negatively affected by an increasing number of shares.

Did Mineralys Therapeutics Common ever had a Stock Split?

No Stock Splits found.
Year Number of Shares Growth Rate
2020 5,000,000
2021 39,056,700 +681.13%
2022 40,856,700 +4.61%
2023 40,093,200 -1.87%
2024 49,957,900 +24.6%